G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
G protein-coupled estrogen receptor (GPER) is known to play an important role in hormone-associated cancers. G-1, a novel synthetic GPER agonist, has been reported to exhibit anti-carcinogenic properties. However, the chemotherapeutic mechanism of GPER is yet unclear. Here, we evaluated GPER expression in human gastric cancer tissues and cells. We found that G-1 treatment attenuates GPER expression in gastric cancer. GPER expression increased G-1-induced antitumor effects in mouse xenograft model. We analyzed the effects of knockdown/overexpression of GPER on G-1-induced cell death in cancer cells. Increased GPER expression in human gastric cancer cells increased G-1-induced cell death via increased levels of cleaved caspase-3, -9, and cleaved poly ADP-ribose polymerase. Interestingly, during G-1-induced cell death, GPER mRNA and protein expression was attenuated and associated with ER stress-induced expression of PERK, ATF-4, GRP-78, and CHOP. Furthermore, PERK-dependent induction of ER stress activation increased G-1-induced cell death, whereas PERK silencing decreased cell death and increased drug sensitivity. Taken together, the data suggest that the induction of ER stress via GPER expression may increase G-1-induced cell death in gastric cancer cells. These results may contribute to a new paradigm shift in gastric cancer therapy.
Abstract
G protein-coupled estrogen receptor (GPER) is known to play an important role in hormone-associated cancers. G-1, a novel synthetic GPER agonist, has been reported to exhibit anti-carcinogenic properties. However, the chemotherapeutic mechanism of GPER is yet unclear. Here, we evaluated GPER expression in human gastric cancer tissues and cells. We found that G-1 treatment attenuates GPER expression in gastric cancer. GPER expression increased G-1-induced antitumor effects in mouse xenograft model. We analyzed the effects of knockdown/overexpression of GPER on G-1-induced cell death in cancer cells. Increased GPER expression in human gastric cancer cells increased G-1-induced cell death via increased levels of cleaved caspase-3, -9, and cleaved poly ADP-ribose polymerase. Interestingly, during G-1-induced cell death, GPER mRNA and protein expression was attenuated and associated with ER stress-induced expression of PERK, ATF-4, GRP-78, and CHOP. Furthermore, PERK-dependent induction of ER stress activation increased G-1-induced cell death, whereas PERK silencing decreased cell death and increased drug sensitivity. Taken together, the data suggest that the induction of ER stress via GPER expression may increase G-1-induced cell death in gastric cancer cells. These results may contribute to a new paradigm shift in gastric cancer therapy.
참고문헌 (15)
- 박강서, "HSP90 inhibitor, AUY922, debilitates intrinsic and acquired lapatinib-resistant HER2-positive gastric cancer cells", BMB Reports, 51(12), pp.660~665 (2018), 생화학분자생물학회
- 서재성, "Inhibition of Wntless", GPR177 suppresses gastric tumorigenesis, 2018, pp.51(5), 255~260[DOI]
- Simon MS, "Estrogen plus progestin and colorectal cancer incidence and mortality", J Am Soc Clin Oncol, 30, pp.3983~3990 (2012)
- Ariazi EA, "The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells", Cancer Res, 70, pp.1184~1194 (2010)
- Wang C, "The G protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization", Cell Death Dis, 4, pp.e869~ (2013)
- Girgert R, "Inactivation of GPR30 reduces growth of triple-negative breast cancer cells : possible application in targeted therapy", Breast Cancer Res Treat, 134, pp.199~205 (2012)
- Chan QKY, "Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1", 2, c-jun, Cell Death Differ, pp.2010, 17[DOI]
- Bologa CG, "Virtual and biomolecular screening converge on a selective agonist for GPR30", Nature chemical biology, 2, pp.207~212 (2006)
- Prossnitz ER, "Estrogen biology : new insights into GPER function and clinical opportunities", Mol Cell Endocrionol, 389, pp.71~83 (2014)
- Prossnitz ER, "The G-protein-coupled estrogen receptor GPER in health and disease", Nat Rev Endocrinol, 7, pp.715~726 (2011)
- Teng J, "The GPER inhibits human urothelial cell proliferation", Endocrinology, 149, pp.4024~4034 (2008)
- Cortes E, "GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment", EMBO Rep, pp.e46556~ (2018)
- Sano R, "ER stress-induced cell death mechanisms", Biochim Biophys Acta, 1833, pp.3460~3470 (2013)
- Tsai TC, "7-Acetylsinumaximol B Induces Apoptosis and Autophagy in Human Gastric Carcinoma Cells through Mitochondria Dysfunction and Activation of the PERK", eIF2, CHOP Signaling Pathway, pp.Mars Drugs, 2018[DOI]
- Xiaokun Wang, "ER membrane protein complex subunit 6 (EMC6) is a novel tumor suppressor in gastric cancer", BMB Reports, 50(8), pp.411~416 (2017), 생화학분자생물학회